Entity Common Stock, Shares Outstanding of ACTUATE THERAPEUTICS, INC. from Q3 2024 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Actuate Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2024 to Q3 2025.
  • Actuate Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 12, 2025 was 23.2M shares, a 19% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)

ACTUATE THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 23.2M +3.71M +19% Nov 12, 2025 10-Q 2025-11-13
Q2 2025 20.7M Aug 13, 2025 10-Q 2025-08-14
Q1 2025 19.5M Mar 10, 2025 10-K 2025-03-13
Q3 2024 19.5M Sep 23, 2024 10-Q 2024-09-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.